To help with new pilot models aimed at lowering drug costs across Medicaid and Medicare, CMS’ innovation center is ramping up staff. “We are on

Aldeyra Therapeutics was hoping the third time would be the charm for its dry eye drug this St. Patrick’s Day. No such luck. The FDA

The biopharma industry is looking for creative ways to cushion the effect of the Trump administration’s “most favored nation” deals on US pricing. Two lawyers

Epic last week scored a win in a lawsuit that revolves around who has a right to patient health data. On Friday, the electronic health

Plus, news about Genentech, Mestag and BioVie: 📊 Pfizer says next-gen breast cancer drug succeeds in Phase 2: The company is developing a CDK4 inhibitor